CliffBio
small molecule

TRIFERIC AVNU

FERRIC PYROPHOSPHATE CITRATE

Loss of exclusivityApril 2029latest FDA-listed patent expiry
CompanyRockwell Medical →View the full company profile on CliffBio

Drug detail

Brand nameTRIFERIC AVNU
Active ingredientFERRIC PYROPHOSPHATE CITRATE
Strength6.75MG IRON/4.5ML (1.5MG IRON/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMarch 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
7816404April 2029substance

More from Rockwell Medical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TRIFERIC AVNU patent cliff — loss of exclusivity April 2029 | CliffBio